Sign in

NCT07123220Completed

Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus

Identification of Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus. A Multicenter Cross-sectional Cohort Study

Source: ClinicalTrials.gov · Last updated 13 Feb 2026

Brief summary (registry, in English)

Introduction: Fatigue is a well-established symptom in systemic lupus erythematosus. Depression and anxiety can develop at different stages of systemic lupus erythematosus and their severity can range from mild symptoms to more serious disorders. Patients with systemic lupus erythematosus may consider fatigue to be a symptom that is more severe than pain, depression, or anxiety. Objectives: To describe fatigue in patients with systemic lupus erythematosus and identify the best predictive model for fatigue in these patients. Methods: Multicenter cross-sectional cohort studies. Eighty-eight patients with systemic lupus erythematosus from different regions of Spain will be included in the studies. The primary variable will be fatigue (Fatigue Assessment Scale), with anxiety (State-Trait Anxiety Inventory) as the dependent variable. The secondary variables will be perceived quality of life (Lupus Quality of Life and 36-Item Short Form Survey Instrument), level of physical activity (International Physical Activity Questionnaire), and the main clinical, sociodemographic, and anthropometric variables. Expected results: To describe fatigue in patients with systemic lupus erythematosus, as well as the predictive model for fatigue in these patients.

Status (registry)
Completed
Study type
Observational
Enrollment
884 (actual)
First submitted
7 Aug 2025
Start date
1 Sept 2025
Primary completion date
13 Nov 2025
Lead sponsor
Investigación en Hemofilia y Fisioterapia
Diseases
Lupus (SLE)
NCT number
NCT07123220

What you commit to

  • Study type: Observational
  • Participants enrolled: 884
  • From 1 Sept 2025 to the primary completion date, 13 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who are receiving an intervention (physiotherapy or orthopedic) at the time of the study.

Other

  • Patients with neurological or cognitive impairments that prevent them from understanding the questionnaires and physical tests.

Who the study is looking for

  • Patients diagnosed with systemic lupus erythematosus.
  • Over 18 years of age.
  • Who have not had any flare-ups in the last 6 months.
  • Who sign the informed consent form.

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universidad de Oviedo
Coordinator of this site? Confirm its status
AlmeríaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.